inflammatory bowel diseases

Artificial sweetener Splenda could intensify Symptoms in those with Crohn’s disease

In a study that has implications for humans with inflammatory diseases, researchers from Case Western Reserve University School of Medicine and colleagues have found that, given over a six-week period, the artificial sweetener sucralose, known by the brand name Splenda, worsens gut inflammation in mice with Crohn’s-like disease, but had no substantive effect on those without the condition. Crohn’s disease ...

Read More »

AGA Launches New Patient App to Aid in Inflammatory Bowel Disease (IBD) Monitoring and Education

The American Gastroenterological Association (AGA) today announced the launch of My IBD Manager, a new digital patient resource developed for the 1.6 million Americans living with Crohn’s disease and ulcerative colitis, collectively known as inflammatory bowel disease (IBD), and the doctors who treat them. This will be followed by the launch of an online clinical platform for health care professionals, ...

Read More »

Gut reaction: Repeated food poisoning triggers chronic disease

A startling discovery published in the journal Science reveals how your past history of minor bacterial infections can add up with age to cause a severe inflammatory disease. Small bacterial infections that may go unnoticed and which the body easily clears without treatment, such as occurs during mild food poisoning, nevertheless can start a chain of events that leads to ...

Read More »

People living in rural households have lower risk of developing inflammatory bowel disease

Living in rural households decreases a person’s risk of developing inflammatory bowel disease (IBD), particularly for young children and adolescents, according to a new study by researchers at the Children’s Hospital of Eastern Ontario (CHEO) Research Institute, Institute for Clinical Evaluative Sciences (ICES), and the Canadian Gastro-Intestinal Epidemiology Consortium (CanGIEC). “Our findings show that children, particularly those under the age ...

Read More »

Crohn’s & Colitis Foundation Launches New IBD Clinical Trials Community to Educate and Support Clinical Trial Participation

Clinical trial recruitment is a challenging step toward FDA approval of new treatments for patients across all disease states; this is especially true for inflammatory bowel diseases (IBD). The Crohn’s & Colitis Foundation (the Foundation) launched today a dedicated Clinical Trials Community (the Community) for IBD. The Community is designed to educate patients, caregivers, and healthcare providers about the clinical ...

Read More »